You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fibrinolysin

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Retinopathy, Posterior Vitreous Detachment, Disease Progression Trial in Worldwide (ocriplasmin 0.0625mg, ocriplasmin

Terminated
Has Results
  • Diabetic Retinopathy
  • +2 more
  • ocriplasmin 0.0625mg
  • +2 more
  • Phoenix, Arizona
  • +37 more
Dec 8, 2020

Vitreoretinal Traction Syndrome Trial in Cleveland (Plasmin)

Terminated
  • Vitreoretinal Traction Syndrome
  • Cleveland, Ohio
    University Hospitals of Cleveland
Jun 20, 2019

Vitreoretinal Traction Syndrome Trial in Atlanta (Plasmin, Vehicle)

Terminated
  • Vitreoretinal Traction Syndrome
  • Atlanta, Georgia
    Emory University
Jun 20, 2019

Acquired Thrombotic Thrombocytopenic Purpura Trial in Shanghai (Anfibatide, Placebos)

Unknown status
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Shanghai, Shanghai, China
    Shanghai Ruijing Hospital
Jul 15, 2019

Hemophilia, Factor XIII Deficiency Trial in Orange (Fibrogammin P)

Completed
Has Results
  • Hemophilia
  • Factor XIII Deficiency
  • Fibrogammin P
  • Orange, California
    Children's Hospital of Orange Co.
Oct 11, 2018

Coronary Artery Disease Trial in Nanjing (tirofiban in PV, tirofiban in IC, antiplatelet thrombolysin)

Unknown status
  • Coronary Artery Disease
  • tirofiban in PV
  • +5 more
  • Nanjing, Jiangsu, China
    First Affiliated Hospital of Nanjing Medical University
Mar 7, 2017

Arterial Occlusive Diseases Trial in Toledo (Plasmin (Human) 25 mg, Plasmin (Human) 50 mg, Plasmin (Human) 75 mg)

Completed
  • Arterial Occlusive Diseases
  • Plasmin (Human) 25 mg
  • +6 more
  • Toledo, Ohio
    Jobst Vascular Institute
Oct 28, 2016

Acute Peripheral Arterial Occlusion Trial in Worldwide (Plasmin, Plasminogen Activator, Placebo)

Completed
Has Results
  • Acute Peripheral Arterial Occlusion
  • Plasmin
  • +2 more
  • Buffalo, New York
  • +38 more
Nov 28, 2016

Acute Ischemic Stroke Trial in Worldwide (Plasmin (Human))

Completed
Has Results
  • Acute Ischemic Stroke
  • Plasmin (Human)
  • Heidelberg, Victoria, Australia
  • +22 more
Sep 22, 2015

Stroke, Acute Trial in Austria, Belgium, Germany (Microplasmin)

Completed
  • Stroke, Acute
  • Graz, Austria
  • +15 more
Nov 6, 2014

Vitrectomy Trial in United States (Ocriplasmin 25µg, Ocriplasmin 75µg, Ocriplasmin 125µg)

Completed
Has Results
  • Vitrectomy
  • Ocriplasmin 25µg
  • +3 more
  • Tucson, Arizona
  • +19 more
Dec 2, 2014

Vitrectomy Trial in Leuven (ocriplasmin)

Completed
Has Results
  • Vitrectomy
  • Leuven, Belgium
    University Hospital Leuven
Dec 2, 2014

Vitreomacular Traction Trial in Belgium, Germany (ocriplasmin, Sham Comparator)

Completed
Has Results
  • Vitreomacular Traction
  • Antwerpen, Belgium
  • +3 more
Dec 2, 2014

Arterial Occlusive Diseases Trial in Leuven (Microplasmin)

Terminated
  • Arterial Occlusive Diseases
  • Leuven, Belgium
    University Hospital Gasthuisberg
Apr 4, 2014

Factor XIII Deficiency Trial in United States (FXIII Concentrate (Human) (FXIII))

Completed
Has Results
  • Factor XIII Deficiency
  • FXIII Concentrate (Human) (FXIII)
  • Dothan, Alabama
  • +24 more
Sep 12, 2012

Factor XIII Deficiency Trial in Spain, United States (FXIII Concentrate (Human))

Completed
Has Results
  • Factor XIII Deficiency
  • FXIII Concentrate (Human)
  • Dothan, Alabama
  • +22 more
Jul 10, 2012

Factor XIII Deficiency Trial in Spain, United States (FXIII Concentrate (Human))

Completed
Has Results
  • Factor XIII Deficiency
  • FXIII Concentrate (Human)
  • Dothan, Alabama
  • +5 more
Dec 7, 2011